Hepatitis C is a predictor of poorer renal survival in diabetic patients

Diabetes Care

Volumn 28, Issue 9, 2005, Pages 2187-2191

  Crook, Errol D ^a,b,c,d   Penumalee, Sreelatha ^a,c   Gavini, Bharathi ^a,c   Filippova, Kseniya ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DETROIT MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HAZARD ASSESSMENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KAPLAN MEIER METHOD; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEPHROLOGY; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; SURVIVAL;

AGE OF ONSET; ANALYSIS OF VARIANCE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEPATITIS C; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 24144487177     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.9.2187     Document Type: Review

References (26)

1. Rakela J, Vargas HE: Hepatitis C: magnitude of the problem (Review). Liver Transplantation 8 (10 Suppl. 1):S3-S6, 2002
2. Kim WR: The burden of hepatitis C in the United States (Review). Hepatology 36 (5 Suppl. 1):S30-S34, 2002
3. Diego JM, Roth D: Treatment of hepatitis C infection in patients with renal disease (Review). Curr Opin Nephrol Hypertens 7:557-562, 1998
4. Gopalani A, Ahuja TS: Prevalence of glomerulopathies in autopsies of patients infected with the hepatitis C virus. Am J Med Sci 322:57-60, 2001
5. Meyers DM, Seeff LB, Stehman-Breen CO, Hoofnagle JH: Hepatitis C and renal disease: an update. Am J Kidney Dis 42:631-657, 2003
6. Soma J, Saito T, Taguma Y, Chiba S, Sato H, Sugimura K, Ogawa S, Ito S: High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc of Nephrol 11: 690-699, 2000
7. Stehman-Breen C, Alpers CE, Fleet WP, Johnson RJ: Focal segmental glomerular sclerosis among patients infected with hepatitis C virus. Nephron 81:37-40, 1999
8. Sulkowski MS, Thomas DL: Hepatitis C in the HIV-infected person. Ann Intern Med 138:197-207, 2003
9. Hsu C, Vittinghoff E, Lin F, Shilpak MG: The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 141:95-101, 2004
10. Crook ED: Diabetic renal disease in African Americans. Am J of Med Sci 323:78-84, 2002
11. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ: The excess incidence of diabetic end-stage renal disease among blacks: a population-based study of potential explanatory factors. JAMA 268: 3079-3084, 1992
12. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J: High prevelence of hepatitis C virus infection in diabetic patients. Diabetes Care 19:998-1000, 1996
13. Allison MED, Wreghitt T, Palmer CR, Alexander GJM: Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatology 21:1135-1139, 1994
14. Gray H, Wreghitt T, Stratton IM, Alexander GJM, Turner RC, O'Rahily S: High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 12:244-249, 1994
15. Levey AS, Greene T, Kusek JB, Beck GJ: A simplified equation to predict glomerular filtration rate from serum creatinine (Abstract). J Am Soc Nephrol 11:A0828, 2000
16. National Kidney Foundation K/DOQI Working Group: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39:576-592, 2002
17. Nishizawa Y, Shoji T, Ishimura E, Inaba M, Morii H: Cardiovascular complications in uremia: Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis 38 (Suppl. 1):S4-S7, 2001
18. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis: report of the Diaphane collaborative study. Nephron 31:103-110, 1982
19. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK: Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55:1560-1567, 1999
20. Filippova K, Galla R, Penumalee S, Crook ED: Predictors of renal survival in hepatitis C patients (Abstract). J Am Soc Nephrol 15:335A, 2004
21. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, Deforges L, Duvoux C, Zafrani ES, Duval J, Dhumeaux D: Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 10:841-848, 1994
22. Kendrick EA, McVicar JP, Kowdley KV, Bronner MP, Emond MJ, Alpers CE, Gretch DR, Carithers RL Jr, Perkins JD, Davis CL: Renal disease in hepatitis C-positive liver transplant recipients. Transplantation 63:1287-1293, 1997
23. Thuluvath PJ, John PR: Association between hepatitis C, diabetes mellitus, and race: a case-control study. Am J Gastroenterol 98:438-441, 2003
24. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC: Association of hepatitis C with posttransplant diabetes in renal transplantation patients on tacrolimus. J Am Soc Nephrol 13:1374-1380, 2002
25. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M: Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 283:2253-2259, 2000
26. Crook ED, Harris J, Oliver B, Fleischman E, Crenshaw G, Taylor R: Endstage renal disease due to diabetic nephropathy in Mississippi: an examination of factors influencing renal survival in a population prone to late referral. J Invest Med 49:284-291, 2001